0001564590-21-036025.txt : 20210708 0001564590-21-036025.hdr.sgml : 20210708 20210708060306 ACCESSION NUMBER: 0001564590-21-036025 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210708 FILED AS OF DATE: 20210708 DATE AS OF CHANGE: 20210708 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Taiwan Liposome Company, Ltd. CENTRAL INDEX KEY: 0001722890 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: F5 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38746 FILM NUMBER: 211078893 BUSINESS ADDRESS: STREET 1: 2F, 3 YUANQU STREET STREET 2: NANGANG DISTRICT CITY: TAIPEI CITY STATE: F5 ZIP: 11503 BUSINESS PHONE: 886 2 2655 7377 MAIL ADDRESS: STREET 1: 2F, 3 YUANQU STREET STREET 2: NANGANG DISTRICT CITY: TAIPEI CITY STATE: F5 ZIP: 11503 6-K 1 tlc-6k_20210708.htm 6-K tlc-6k_20210708.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the Month of July 2021

Commission File Number: 001-38746

 

Taiwan Liposome Company, Ltd.

(Translation of registrant’s name into English)

 

Taiwan Liposome Company, Ltd.

11F-1, No. 3 Yuanqu Street

Nangang District,

Taipei City, Taiwan 11503

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F  ☒

 

Form 40-F  ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

 


 

 

 

Filings with the Taipei Exchange dated July 6, 2021

 

On July 6, 2021, Taiwan Liposome Company, Ltd. (the “Company”) made supplement filings with the Taipei Exchange’s Market Observation Post System to confirm the venue of the rescheduled 2021 Annual General Meeting and an Extraordinary General Meeting to consider, among others, the proposed privatization previously mentioned in the Form 6-K dated July 6, 2021.

A copy of the Taipei Exchange’s Market Observation Post System filings is attached hereto as Exhibit 99.1.

 

 

Exhibits

 

Exhibit

Number

 

Exhibit Description

  99.1

 

Filings with the Taipei Exchange’s Market Observation Post System, dated July 6, 2021.

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

 

TAIWAN LIPOSOME COMPANY, LTD.

 

 

 

Date: July 8, 2021

 

By:

 

/s/ George Yeh

 

 

Name:

 

George Yeh

 

 

Title:

 

President

 

 

 

 EX-99.1 2 tlc-ex991_9.htm EX-99.1 tlc-ex991_9.htm

Exhibit 99.1

Filings with the Taipei Exchange’s Market Observation Post System,

dated July 6, 2021

No:1

Subject: Announcement the Company's Board of Directors has resolved the postponed date of annual shareholders' meeting (Updated)

To which item it meets--article 4 paragraph xx:17

Date of events: 2021/07/05

Contents:

1. Date of the board of directors' resolution: 2021/07/05

2. General shareholders' meeting date: 2021/08/19

3. General shareholders' meeting time: 09:00 AM

4. General shareholders' meeting location: 7F, No. 3, Yuanqu St., Nangang Dist., Taipei

5. Regarding cause for convening the general shareholders' meeting, please refer to the material information of the company: 2021/03/30

6. Method of convening shareholders meeting (in person / in person or attendance by video conferencing): in person

7. Any other matters that need to be specified: Shareholders whose register of shareholders, which was scheduled to stop transfer at the 2021/6/29 shareholders' meeting, have the right to attend the shareholders' meeting.


 

No:2

Subject: The Board of the Company resolved to convene the first extraordinary general meeting of 2021 (Updated)

To which item it meets--article 4 paragraph xx:17

Date of events: 2021/07/05

Contents:

1. Date of the board of directors' resolution: 2021/07/05

2. Extraordinary shareholders' meeting date: 2021/08/20

3. Extraordinary shareholders' meeting location: 7F, No. 3, Yuanqu St., Nangang Dist., Taipei

4. Cause for convening the meeting I. Reported matters:

(1) Amendments to the Company’s 2020 and 2018 employee stock option grant and subscription plans

(2) Report of special committee for merger and acquisition

5. Cause for convening the meeting II. Acknowledged matters: None

6. Cause for convening the meeting III. Matters for Discussion:

(1) To approve share swap with Woods Investment Company, Ltd. and application for termination of TPEx trading according to Business Mergers and Acquisitions Act

(2) To approve cease the Company’s status as a public company

(3) To approve amendments to the Company’s article of incorporation

7. Cause for convening the meeting IV. Election matters: None

8. Cause for convening the meeting V. Other Proposals: None

9. Cause for convening the meeting VI. Extemporary Motions: None

10. Book closure starting date: 2021/07/22

11. Book closure ending date: 2021/08/20

12. Whether to announce proposal for profit distribution or loss off-setting in “Status of dividend distribution” section of MOPS: NA

13. Please explain the reason for not announcing proposal for profit distribution or loss off-setting: NA

14. Any other matters that need to be specified: None